The importance of community engagement to effective research cannot be overstated. This is one reason why the Community Engagement team at UB’s Clinical and Translational Science Institute (CTSI) ...

ALS San Diego supports over 200 individuals living with ALS and their families in San Diego, along with other ALS families that visit our community each year from all over the world.

Community engagement for Lou Gehrig Day across more than 17 MLB teams (June 2) Hosting MDA Wings Over Wall Street Gala in NYC benefitting ALS Research (June 6) and honoring members of the ALS ...

MINNETONKA, Minnesota (WCCO) — A Minnetonka woman is helping connect the ALS community through an app. On Jan. 5, 2022, Faith’s son, Scott, was diagnosed with ALS. ALS is a fatal neurological ...

HONOR the Challenger: Promoting Global Awareness Through Social Engagement. To bring attention back to the ALS community while paying tribute to the challengers who live with the disease, BBC ...

The viral hashtag garnered 85,000,000 views and generated a total global engagement of 11,000,000, raising global attention for the important cause. “I was inspired by the challenger spirit behind ...

Here’s Why ALS Drug Relyvrio Is Being Removed From Market—And What That ... engagement with regulatory authorities, and discussions with the ALS community,” Joshua Cohen and Justin ...

SHENZHEN, China, Aug. 13, 2024 /PRNewswire/ -- A trending social challenge has raised significant awareness for the ALS community, serving as a catalyst for the advancement of accessible technology.

Implementation of the Ontario Provincial ALS Program is critical for addressing the urgent needs of Ontarians living with ALS and their families ALS community calls on the Ontario government to ...

After disappointing phase 3 trial results in ALS, ... engagement with regulatory authorities, and discussions with the ALS community," Cohen and Klee said. ...

Relyvrio was first approved by the U.S. Food and Drug Administration in September 2022, following a lengthy, impassioned campaign by patients with ALS, a fatal muscle-wasting disease.